Valion Bio, Inc.
financial.report · SEC EDGAR
This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.
Event type
financial.report
Occurred
2026-03-31
Reported
2026-05-14
Disclosure lag
44 days
Context
links are based on the recorded entity type| Field | Recorded value |
|---|---|
| Entity | Valion Bio, Inc. |
| Source | SEC EDGAR ↗ |
| News section | Unclassified |
| Source identifier | companyfacts/CIK0001787740/2026-07-26 |
| Source-linked related entities | None recorded |
| Event ID | #51396 |
Related recorded events
same canonical or source-linked entity relations| Reported | Type | Event | Source |
|---|---|---|---|
| 2026-07-17 | New filing | Event #21351 | SEC EDGAR |
| 2026-07-17 | New filing | Event #21342 | SEC EDGAR |
| 2026-07-14 | New filing | Event #22437 | SEC EDGAR |
| 2026-03-30 | financial.report | Event #51393 | SEC EDGAR |
| 2025-11-14 | financial.report | Event #51395 | SEC EDGAR |
| 2025-08-14 | financial.report | Event #51394 | SEC EDGAR |
Recorded payload
JSON payload as stored after parsing{
"accession": "0001437749-26-017142",
"canonical_covered": 12,
"canonical_total": 12,
"fiscal_period": "Q1",
"fiscal_year": 2026,
"form": "10-Q",
"mapped_tag_share": 0.048701298701298704,
"metrics": {
"cash_and_equivalents": 7215000,
"earnings_per_share_basic": -2.23,
"net_income": -6202000,
"operating_cash_flow": -5011000,
"operating_income": -5634000,
"shareholders_equity": 11062000,
"shares_outstanding": 2879857,
"total_assets": 38215000,
"total_liabilities": 19667000
},
"metrics_reported": 9,
"period_end": "2026-03-31"
}Evidence-based analysis
facts, provenance and explicit model coverageDescriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.
| Dimension | Status / value | Method or boundary |
|---|---|---|
| What happened | not_covered | The source record has no short title or summary. |
| When | source_backed · reported 2026-05-14 | Occurred 2026-03-31. Source-record timestamps; no timezone or event time is inferred. |
| Affected entities | resolved · Valion Bio, Inc. · 0 related | Canonical primary entity and stored related_entity_ids only. |
| Event classification | financial · financial.report | canonical event type plus source-provided category; no sentiment or impact is inferred |
| Entity linking | resolved | Canonical entity resolved during ingestion |
| Deduplication | applied | unique source event key at ingestion |
| Source trust | high · terms allowed | Source registry metadata |
| Sentiment | not_covered | No sentiment model output is published for this record. |
| Market reaction | not_covered | Requires licensed quote, candle and volume observations for the affected instrument. |
| Historical analogs | not_covered | Requires an audited event-cluster corpus and matching methodology. |
| Impact mechanism | not_covered | No causal market-impact model is published for this record. |
| Related risks | not_covered | Risk implications require an audited instrument/entity exposure model. |
| Instrument linkage | not_covered | No instrument relation is inferred from an entity event; licensed instrument mapping is required. |
Source: SEC EDGAR · as of 2026-05-14T00:00:00Z